Status:
COMPLETED
Optimizing PrEP Utilization Among Alcohol and Other Drug (AOD) Using Women of Color
Lead Sponsor:
Florida International University
Conditions:
HIV Prevention
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Nationally, the HIV case rate among black/ African American (AA) women is nearly 20 times higher than in white women; for Hispanic/Latino women it is 4.5 times higher. Moreover, according to findings ...
Detailed Description
A singular limitation in the fight against HIV has been the absence of practical female-controlled prevention strategies and relative dependence on cooperative use of the male condom. Since 2012, medi...
Eligibility Criteria
Inclusion
- 18 + years of age;
- born female;
- Identifies as female;
- Identifies as African American, Hispanic/Latina or Haitian (self or parent);
- Able to provide informed consent;
- HIV uninfected;
- Sexual risk (previous STI, inconsistent condom use, transactional sex, HIV infected partner);
- History of alcohol or drug use in last 3 months;
- No uncleared PrEP contraindications;
- No psychosis.
Exclusion
- Less than 18 years of age
- male gender assignment at birth
- current male gender identity
- does not identify as African American, Haitian or Hispanic/Latina (self or parent)
- reports history of or current untreated psychosis
- unable to provide informed consent
- HIV infected
- Refuses PrEP medication
- Untreated medical contraindication for PrEP
Key Trial Info
Start Date :
May 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04018651
Start Date
May 31 2019
End Date
August 31 2022
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida International University Biscayne Bay Campus
North Miami, Florida, United States, 33181